These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 33432808)

  • 21. A substrate for a cell free in vitro assay system to screen drugs targeting trypsin like protease-based cleavage of SARS-CoV-2 spike glycoprotein and viral entry.
    Begum F; Srivastava AK; Tripathi PP; Ray U
    J Med Virol; 2023 May; 95(5):e28796. PubMed ID: 37218551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve
    Shiliaev N; Lukash T; Palchevska O; Crossman DK; Green TJ; Crowley MR; Frolova EI; Frolov I
    J Virol; 2021 Oct; 95(21):e0135721. PubMed ID: 34406867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of protease-mediated processes initiating viral infection and cell-cell viral spreading of SARS-CoV-2.
    Thaingtamtanha T; Baeurle SA
    J Mol Model; 2022 Jul; 28(8):224. PubMed ID: 35854129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion.
    Papa G; Mallery DL; Albecka A; Welch LG; Cattin-Ortolá J; Luptak J; Paul D; McMahon HT; Goodfellow IG; Carter A; Munro S; James LC
    PLoS Pathog; 2021 Jan; 17(1):e1009246. PubMed ID: 33493182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteolytic activation of the spike protein at a novel RRRR/S motif is implicated in furin-dependent entry, syncytium formation, and infectivity of coronavirus infectious bronchitis virus in cultured cells.
    Yamada Y; Liu DX
    J Virol; 2009 Sep; 83(17):8744-58. PubMed ID: 19553314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis.
    Johnson BA; Xie X; Bailey AL; Kalveram B; Lokugamage KG; Muruato A; Zou J; Zhang X; Juelich T; Smith JK; Zhang L; Bopp N; Schindewolf C; Vu M; Vanderheiden A; Winkler ES; Swetnam D; Plante JA; Aguilar P; Plante KS; Popov V; Lee B; Weaver SC; Suthar MS; Routh AL; Ren P; Ku Z; An Z; Debbink K; Diamond MS; Shi PY; Freiberg AN; Menachery VD
    Nature; 2021 Mar; 591(7849):293-299. PubMed ID: 33494095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The sequence at Spike S1/S2 site enables cleavage by furin and phospho-regulation in SARS-CoV2 but not in SARS-CoV1 or MERS-CoV.
    Örd M; Faustova I; Loog M
    Sci Rep; 2020 Oct; 10(1):16944. PubMed ID: 33037310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metalloproteinase-Dependent and TMPRSS2-Independent Cell Surface Entry Pathway of SARS-CoV-2 Requires the Furin Cleavage Site and the S2 Domain of Spike Protein.
    Yamamoto M; Gohda J; Kobayashi A; Tomita K; Hirayama Y; Koshikawa N; Seiki M; Semba K; Akiyama T; Kawaguchi Y; Inoue JI
    mBio; 2022 Aug; 13(4):e0051922. PubMed ID: 35708281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.
    Frolova EI; Palchevska O; Lukash T; Dominguez F; Britt W; Frolov I
    J Virol; 2022 Aug; 96(15):e0075322. PubMed ID: 35876526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition.
    Navaratnarajah CK; Pease DR; Halfmann PJ; Taye B; Barkhymer A; Howell KG; Charlesworth JE; Christensen TA; Kawaoka Y; Cattaneo R; Schneider JW;
    J Virol; 2021 Nov; 95(24):e0136821. PubMed ID: 34613786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cryptococcal Protease(s) and the Activation of SARS-CoV-2 Spike (S) Protein.
    Mjokane N; Maliehe M; Folorunso OS; Ogundeji AO; Gcilitshana OMN; Albertyn J; Pohl CH; Sebolai OM
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation.
    Hörnich BF; Großkopf AK; Schlagowski S; Tenbusch M; Kleine-Weber H; Neipel F; Stahl-Hennig C; Hahn AS
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33608407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways.
    Laporte M; Raeymaekers V; Van Berwaer R; Vandeput J; Marchand-Casas I; Thibaut HJ; Van Looveren D; Martens K; Hoffmann M; Maes P; Pöhlmann S; Naesens L; Stevaert A
    PLoS Pathog; 2021 Apr; 17(4):e1009500. PubMed ID: 33886690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epitope-directed anti-SARS-CoV-2 scFv engineered against the key spike protein region could block membrane fusion.
    Jaiswal D; Kumar U; Gaur V; Salunke DM
    Protein Sci; 2023 Mar; 32(3):e4575. PubMed ID: 36691733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential glycosylations at the multibasic cleavage site of SARS-CoV-2 spike protein regulate viral activity.
    Wang S; Ran W; Sun L; Fan Q; Zhao Y; Wang B; Yang J; He Y; Wu Y; Wang Y; Chen L; Chuchuay A; You Y; Zhu X; Wang X; Chen Y; Wang Y; Chen YQ; Yuan Y; Zhao J; Mao Y
    Nat Commun; 2024 May; 15(1):4162. PubMed ID: 38755139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The "LLQY" Motif on SARS-CoV-2 Spike Protein Affects S Incorporation into Virus Particles.
    Du S; Xu W; Wang Y; Li L; Hao P; Tian M; Wang M; Li T; Wu S; Liu Q; Bai J; Qu X; Jin N; Zhou B; Liao M; Li C
    J Virol; 2022 Mar; 96(6):e0189721. PubMed ID: 35045269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.
    Cheng YW; Chao TL; Li CL; Wang SH; Kao HC; Tsai YM; Wang HY; Hsieh CL; Lin YY; Chen PJ; Chang SY; Yeh SH
    mBio; 2021 Aug; 12(4):e0058721. PubMed ID: 34311586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease.
    Stevaert A; Van Berwaer R; Mestdagh C; Vandeput J; Vanstreels E; Raeymaekers V; Laporte M; Naesens L
    mBio; 2022 Aug; 13(4):e0137622. PubMed ID: 35913162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spike Protein Cleavage-Activation in the Context of the SARS-CoV-2 P681R Mutation: an Analysis from Its First Appearance in Lineage A.23.1 Identified in Uganda.
    Lubinski B; Frazier LE; Phan MVT; Bugembe DL; Cunningham JL; Tang T; Daniel S; Cotten M; Jaimes JA; Whittaker GR
    Microbiol Spectr; 2022 Aug; 10(4):e0151422. PubMed ID: 35766497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple sites on SARS-CoV-2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V.
    Bollavaram K; Leeman TH; Lee MW; Kulkarni A; Upshaw SG; Yang J; Song H; Platt MO
    Protein Sci; 2021 Jun; 30(6):1131-1143. PubMed ID: 33786919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.